[Action of a taurine-nucleotide-vitamin association on carbohydrate metabolism].
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy; D001660:Biliary Tract Diseases / Q000188:drug therapy; D050260:Carbohydrate Metabolism; D003327:Coronary Disease / Q000188:drug therapy; D003920:Diabetes Mellitus / Q000188:drug therapy; D003928:Diabetic Nephropathies / Q000188:drug therapy; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009711:Nucleotides / Q000627:therapeutic use*; D009765:Obesity / Q000188:drug therapy; D011736:Pyridoxine / Q000627:therapeutic use*; D013654:Taurine / Q000627:therapeutic use*; D014805:Vitamin B 12 / Q000627:therapeutic use*
D009711:Nucleotides; D013654:Taurine; D011736:Pyridoxine; D014805:Vitamin B 12
L'azione sul metabolismo glucidico di un'associazione taurina-nucleotidi-vitamine.